CoChat

Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile

Open access

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Abstract

Targeted metabolomics provides an approach to quantify metabolites involved in specific molecular pathways. We applied an electrochemistry-based, targeted metabolomics platform to define changes in tryptophan, tyrosine, purine and related pathways in the depressed and remitted phases of major depressive disorder (MDD). Biochemical profiles in the cerebrospinal fluid of unmedicated depressed (n = 14; dMDD) or remitted MDD subjects (n = 14; rMDD) were compared against those in healthy controls (n = 18; HC). The rMDD group showed differences in tryptophan and tyrosine metabolism relative to the other groups. The rMDD group also had higher methionine levels and larger methionine-to-glutathione ratios than the other groups, implicating methylation and oxidative stress pathways. The dMDD sample showed nonsignificant differences in the same direction in several of the metabolic branches assessed. The reductions in metabolites associated with tryptophan and tyrosine pathways in rMDD may relate to the vulnerability this population shows for developing depressive symptoms under tryptophan or catecholamine depletion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep00667

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (a) Tryptophan pathway metabolites quantitated by the LCECA platform. (b)Tyrosine pathway metabolites quantitated by the LCECA platform. (c) Purine pathway metabolites quantitated by the LCECA platform. (d) Methionine pathway metabolites quantitated by the LCECA platform.
Figure 1 (a) Tryptophan pathway metabolites quantitated by the LCECA platform. (b)Tyrosine pathway metabolites quantitated by the LCECA platform. (c) Purine pathway metabolites quantitated by the LCECA platform. (d) Methionine pathway metabolites quantitated by the LCECA platform.CC BY-NC-SA · PubMed Central
Figure 2 (a) 5HIAA levels in healthy control, depressed MDD, and remitted MDD samples. (b) 5-HIAA/TRP ratios in healthy control, depressed MDD, and remitted MDD samples. (c) HVA levels in healthy control, depressed MDD, and remitted MDD samples. (d) TYR/4HPLA ratios in healthy control, depressed MDD, and remitted MDD samples.
Figure 2 (a) 5HIAA levels in healthy control, depressed MDD, and remitted MDD samples. (b) 5-HIAA/TRP ratios in healthy control, depressed MDD, and remitted MDD samples. (c) HVA levels in healthy control, depressed MDD, and remitted MDD samples. (d) TYR/4HPLA ratios in healthy control, depressed MDD, and remitted MDD samples.CC BY-NC-SA · PubMed Central
Figure 3 (a) Methionine levels in healthy control, depressed MDD, and remitted MDD samples. (b) GSH/MET ratios in healthy control, depressed MDD, and remitted MDD samples. (c) HVA/5HIAA ratios in healthy control, depressed MDD, and remitted MDD samples. (d) XAN/HVA ratios in healthy control, depressed MDD, and remitted MDD samples.
Figure 3 (a) Methionine levels in healthy control, depressed MDD, and remitted MDD samples. (b) GSH/MET ratios in healthy control, depressed MDD, and remitted MDD samples. (c) HVA/5HIAA ratios in healthy control, depressed MDD, and remitted MDD samples. (d) XAN/HVA ratios in healthy control, depressed MDD, and remitted MDD samples.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. Delgado, P. L. Depression: the case for a monoamine deficiency. J Clin Psychiatry 61 Suppl 6, 7–11 (2000).
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition. Washington, DC American Psychiatric Association; 1994.
  3. First, M. B., Spitzer, R. L., Gibbon, M. & William, J. B. W. Structured Clinical Interview fpr DSM-IV-TR Axis 1 disorders, Research Version, Patient Edition (SCID-I/P) New York, NY: New York State Psychiatric Institute, Biometric research; 2002. 73 Maxwell, M. (Bethesda, MD, 1992).

Cited by

See all 76

Metadata

Authors
Kaddurah-Daouk, R., Yuan, P., Boyle, S. H., Matson, W., Wang, Z., Zeng, Z. B., Zhu, H., Dougherty, G. G., Yao, J. K., Chen, G., Guitart, X., Carlson, P. J., Neumeister, A., Zarate, C., Krishnan, R. R., Manji, H. K., & Drevets, W.
Affiliations
  • Duke University (US)
  • National Institutes of Health (US)
  • Edith Nourse Rogers Memorial Veterans Hospital (US)
  • North Carolina State University (US)
  • VA Pittsburgh Healthcare System (US)
  • National University of Singapore (SG)
Corresponding author
Kaddurah-Daouk, Rima
Venue
Scientific Reports
Published
2012-09-19
Volume
2
Issue
1
Pages
667-667
ISSN
2045-2322 (ISSN-L)
OpenAlex
W1971315623
Cited by
76
References
77
Citations by year
2026: 2 · 2025: 3 · 2024: 9 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 9 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 6 · 2013: 5 · 2012: 1
FWCI
1.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • National Institutes of Health
  • National Institute of Mental Health
  • National Institute of General Medical Sciences (R24GM078233)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
major depressive disorder, remission, tryptophan metabolism, tyrosine metabolism, purine metabolism, methionine, methylation, oxidative stress, catecholamine depletion, depression vulnerability
MeSH terms
Adult, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Remission, Spontaneous, Severity of Illness Index, Biogenic Monoamines, Multivariate Analysis, Case-Control Studies, Biosynthetic Pathways, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.